Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
Abstract In the last decade, the use of immunomodulating treatments (IMT) at integrative oncology providers (IOP) increased. IMTs are used to modulate the tumor microenvironment, which might lead to increased response-to-treatment, and the indication of immune checkpoint inhibitors might also be wid...
Main Authors: | Ralf Kleef, Magdolna Dank, Magdolna Herold, Emese Irma Agoston, Julia Lohinszky, Emoke Martinek, Zoltan Herold, Attila Marcell Szasz |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-47802-5 |
Similar Items
-
Author Correction: Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
by: Ralf Kleef, et al.
Published: (2024-01-01) -
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
by: Zoltan Herold, et al.
Published: (2020-02-01) -
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
by: Magdolna Dank, et al.
Published: (2022-08-01) -
Longitudinal Analysis of 1α,25-dihidroxyvitamin D<sub>3</sub> and Homocysteine Changes in Colorectal Cancer
by: Dorottya Mühl, et al.
Published: (2022-01-01) -
Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
by: Magdolna Herold, et al.
Published: (2023-08-01)